SmartLabs and Sonrai Analytics Form Strategic AI Partnership to Accelerate Precision Medicine Discovery
核心洞察
SmartLabs (搜索) and Sonrai Analytics (搜索) announced a global strategic partnership to integrate Sonrai's AI platform, Sonrai Discovery (搜索), into SmartLabs' network of five managed research centers.
The collaboration will provide SmartLabs (搜索)' member companies with exclusive access to AI-driven analytics tools that streamline diagnostic workflows, enhance molecular profiling, and accelerate biomarker (搜索) discovery.
The partnership combines SmartLabs (搜索)' laboratory infrastructure with Sonrai's cloud-based AI platform for precision medicine, enabling biotechnology and pharmaceutical companies to predict scientific outcomes and accelerate drug development.
SmartLabs (搜索) and Sonrai Analytics (搜索) have announced a global strategic partnership that will bring advanced artificial intelligence capabilities directly to biotechnology and pharmaceutical companies through SmartLabs' network of managed research centers. The collaboration integrates Sonrai's AI data management platform, Sonrai Discovery (搜索), with SmartLabs' laboratory infrastructure to accelerate precision medicine research and drug development.
AI Platform Integration Across Research Network
Under the partnership agreement, SmartLabs (搜索) will offer Sonrai's AI advanced analytics platform to its member companies across five managed research centers. The integration will provide member companies with access to Sonrai Discovery (搜索), a cloud-based AI platform designed for precision medicine that empowers biotech and pharmaceutical teams to streamline diagnostic workflows, enhance molecular profiling, and accelerate biomarker (搜索) discovery by integrating imaging and omics data within a secure data ecosystem.
The collaboration extends beyond platform access, with both companies committing to develop new laboratory informatics and bespoke AI applications that will integrate experimental and infrastructure data to predict scientific outcomes and accelerate discovery. These specialized tools will be available exclusively to the SmartLabs (搜索) network, providing member companies with unique competitive advantages in their research efforts.
Addressing Growing Demand for AI-Driven Research Solutions
For SmartLabs (搜索), a leading provider of flexible laboratory infrastructure and operational services solutions, the partnership represents a strategic expansion of its service model to meet the growing demand for AI-driven research solutions. By combining infrastructure, operational, and scientific expertise with Sonrai's advanced analytics capabilities, SmartLabs is equipping its members with tools to manage complex data at scale and accelerate the discovery of meaningful patterns and biomarkers.
"We live in the age of data and AI is what unlocks its true value," said Brian Taylor, CEO of SmartLabs (搜索). "I'm excited about this partnership as it allows us to leverage this newfound power to make a profound difference in human health moving forward."
Precision Medicine Focus and Drug Development Acceleration
Sonrai Analytics (搜索), founded in 2018, specializes in AI precision medicine technology. The company's flagship product, Sonrai Discovery (搜索), is designed to expedite the identification and development of drug or therapeutic targets, improving patient outcomes through AI-powered analysis. The platform enables biotechnology and pharmaceutical companies to confidently select compounds with the highest potential for success in clinical trials, accelerating drug development and mitigating the risk of failures during human trials.
Prof. Darragh McArt, Founder and CEO of Sonrai, emphasized the collaborative potential of the partnership: "At Sonrai, our mission is to power the most important precision medicine breakthroughs through connected data and collaborative science. We are excited to partner with SmartLabs (搜索) to bring the power of AI and advanced analytics directly to their member companies. By enabling faster insights and deeper understanding of complex datasets, we help accelerate groundbreaking discoveries and the development of next-generation personalized therapeutics."
Strategic Impact on Drug Discovery Pipeline
The collaboration aligns with SmartLabs (搜索)' mission to accelerate science and the discovery of life-saving therapies by providing members with cutting-edge research tools across every phase of research and development. With the addition of Sonrai's AI capabilities, SmartLabs members will be empowered to focus their resources on driving innovation across diverse modalities, therapeutic areas, and development stages, potentially bringing transformative treatments to patients faster.
SmartLabs (搜索), founded in 2015, operates on the principle that modern science requires adaptable resourcing infrastructure to future-proof the industry and accelerate scientific breakthroughs. The company's Managed Research Centers allow clients to access private, enterprise-grade R&D infrastructure and manufacturing solutions as-a-service without upfront capital investments, providing end-to-end solutions for life sciences companies across all stages of the innovation lifecycle.